Autism diagnoses in the United States now precede developmental services and interventions, according to a new study.

This edition of By the Numbers logs the continued underrepresentation of Black speakers at neuroscience meetings, mildly-effective cognitive behavioral therapy and early autism diagnoses.

Many autistic children rate the therapy as less effective at treating their anxiety than their parents and clinicians do.

In this week’s Community Newsletter, we dive into two studies that look at how the autism research paradigm could become more inclusive.

Here is a roundup of news and research for the week of 8 November.

An online community is helping many new principal investigators through a tricky time, plus other resources for early-career autism researchers.

Technical issues have plagued the 2021 Society for Neuroscience annual meeting, with presenters unable to log in for their virtual poster sessions and battling auto-captioning quirks.

Cannabis-derived drugs are approved to treat only a small number of autism-related conditions, but many autistic people and their families experiment with medical marijuana to ease autism traits. In this special report, Spectrum rounds up what the science says about cannabis and autism.

The percentage of Black researchers presenting at neuroscience conferences has increased by only a meager amount since the Black Lives Matter protests of 2020.

In this week’s Community Newsletter, we detail the online conversations swirling around the Autism Science Foundation’s statement of support for applied behavior analysis.